A Prospective, One-arm and Open Clinical Study of Anti-CD38 Antibody in the Treatment of Antiphospholipid Syndrome With Secondary Thrombocytopenia

Condition:   Antiphospholipid Syndrome With Secondary Thrombocytopenia Intervention:   Drug: Anti-CD38 antibody Injection Sponsor:   Institute of Hematology & Blood Diseases Hospital Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials